Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 21 | 2025 | 298 | 4.880 |
Why?
|
| Stroke Volume | 6 | 2025 | 122 | 1.490 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 121 | 1.080 |
Why?
|
| Patient Readmission | 3 | 2025 | 118 | 1.000 |
Why?
|
| Ventricular Function, Left | 3 | 2025 | 111 | 0.890 |
Why?
|
| Myocarditis | 2 | 2020 | 24 | 0.890 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2025 | 31 | 0.860 |
Why?
|
| Defibrillators, Implantable | 4 | 2025 | 39 | 0.730 |
Why?
|
| Primary Prevention | 3 | 2025 | 63 | 0.660 |
Why?
|
| Telemetry | 2 | 2010 | 13 | 0.640 |
Why?
|
| Myocardial Infarction | 2 | 2020 | 242 | 0.630 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 96 | 0.610 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2018 | 54 | 0.560 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 531 | 0.540 |
Why?
|
| Cocaine-Related Disorders | 1 | 2018 | 99 | 0.530 |
Why?
|
| Humans | 45 | 2025 | 42113 | 0.530 |
Why?
|
| Digoxin | 1 | 2017 | 10 | 0.530 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2017 | 14 | 0.530 |
Why?
|
| Hypertension | 7 | 2024 | 817 | 0.500 |
Why?
|
| Risk Factors | 12 | 2024 | 3933 | 0.500 |
Why?
|
| Middle Aged | 25 | 2025 | 11790 | 0.500 |
Why?
|
| Dyslipidemias | 1 | 2016 | 48 | 0.480 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 89 | 0.460 |
Why?
|
| Medicaid | 1 | 2017 | 138 | 0.460 |
Why?
|
| Tachycardia, Ventricular | 2 | 2025 | 14 | 0.450 |
Why?
|
| Quality of Life | 1 | 2020 | 598 | 0.450 |
Why?
|
| Atherosclerosis | 1 | 2016 | 164 | 0.430 |
Why?
|
| Healthcare Disparities | 3 | 2023 | 570 | 0.410 |
Why?
|
| Cardiovascular Diseases | 3 | 2024 | 728 | 0.410 |
Why?
|
| Disease Management | 2 | 2025 | 68 | 0.380 |
Why?
|
| United States | 9 | 2024 | 5068 | 0.370 |
Why?
|
| Coronary Angiography | 4 | 2024 | 96 | 0.370 |
Why?
|
| Aged | 17 | 2025 | 7958 | 0.370 |
Why?
|
| Electrocardiography | 3 | 2011 | 183 | 0.350 |
Why?
|
| Aortic Coarctation | 1 | 2011 | 1 | 0.350 |
Why?
|
| Thrombosis | 2 | 2003 | 81 | 0.350 |
Why?
|
| Primary Health Care | 3 | 2023 | 362 | 0.340 |
Why?
|
| Female | 24 | 2025 | 23980 | 0.340 |
Why?
|
| Male | 22 | 2025 | 22745 | 0.330 |
Why?
|
| Hospitalization | 4 | 2017 | 477 | 0.320 |
Why?
|
| Time Factors | 4 | 2024 | 1845 | 0.320 |
Why?
|
| Patient Admission | 1 | 2010 | 50 | 0.320 |
Why?
|
| Heart Diseases | 2 | 2009 | 110 | 0.320 |
Why?
|
| Adult | 15 | 2024 | 13437 | 0.310 |
Why?
|
| Practice Guidelines as Topic | 5 | 2021 | 224 | 0.310 |
Why?
|
| Incidence | 4 | 2024 | 1052 | 0.300 |
Why?
|
| Prognosis | 5 | 2025 | 847 | 0.290 |
Why?
|
| Societies, Medical | 2 | 2025 | 74 | 0.290 |
Why?
|
| Risk Assessment | 5 | 2024 | 844 | 0.270 |
Why?
|
| Pulmonary Edema | 1 | 2007 | 12 | 0.260 |
Why?
|
| Coronary Vessels | 2 | 2011 | 92 | 0.250 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 236 | 0.250 |
Why?
|
| Retrospective Studies | 5 | 2021 | 2466 | 0.250 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2003 | 23 | 0.240 |
Why?
|
| Treatment Outcome | 4 | 2018 | 1582 | 0.230 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2025 | 42 | 0.230 |
Why?
|
| Consensus | 1 | 2025 | 53 | 0.230 |
Why?
|
| Georgia | 5 | 2025 | 189 | 0.220 |
Why?
|
| Shock, Cardiogenic | 1 | 2004 | 10 | 0.220 |
Why?
|
| Heart Block | 1 | 2004 | 4 | 0.220 |
Why?
|
| Cardiac Tamponade | 1 | 2004 | 6 | 0.220 |
Why?
|
| Aortic Diseases | 2 | 2024 | 34 | 0.220 |
Why?
|
| American Heart Association | 1 | 2023 | 21 | 0.210 |
Why?
|
| Health Facilities | 1 | 2023 | 32 | 0.210 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 162 | 0.200 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2004 | 200 | 0.190 |
Why?
|
| Troponin T | 1 | 2022 | 10 | 0.190 |
Why?
|
| Troponin I | 1 | 2022 | 18 | 0.190 |
Why?
|
| Pulmonary Embolism | 1 | 2003 | 38 | 0.190 |
Why?
|
| Cause of Death | 2 | 2024 | 183 | 0.180 |
Why?
|
| Protein S Deficiency | 1 | 2001 | 1 | 0.170 |
Why?
|
| Protein C Deficiency | 1 | 2001 | 1 | 0.170 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2021 | 14 | 0.170 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 704 | 0.170 |
Why?
|
| Stroke | 1 | 2024 | 336 | 0.160 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 637 | 0.140 |
Why?
|
| Arteriosclerosis | 1 | 1998 | 42 | 0.140 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 512 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2011 | 45 | 0.140 |
Why?
|
| Prevalence | 3 | 2016 | 1593 | 0.140 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 163 | 0.130 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 236 | 0.130 |
Why?
|
| Drug Utilization Review | 1 | 2017 | 7 | 0.130 |
Why?
|
| Health Services Accessibility | 3 | 2024 | 680 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2025 | 1570 | 0.130 |
Why?
|
| Propensity Score | 1 | 2017 | 58 | 0.130 |
Why?
|
| Academic Medical Centers | 2 | 2023 | 73 | 0.130 |
Why?
|
| Age Factors | 2 | 2016 | 1135 | 0.130 |
Why?
|
| Odds Ratio | 2 | 2016 | 584 | 0.120 |
Why?
|
| Cost-Benefit Analysis | 2 | 2025 | 175 | 0.120 |
Why?
|
| Young Adult | 2 | 2017 | 4928 | 0.120 |
Why?
|
| Comorbidity | 2 | 2016 | 723 | 0.120 |
Why?
|
| Urban Population | 2 | 2010 | 364 | 0.110 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 263 | 0.110 |
Why?
|
| Logistic Models | 2 | 2016 | 1001 | 0.110 |
Why?
|
| Multicenter Studies as Topic | 2 | 2025 | 61 | 0.110 |
Why?
|
| Disease Progression | 1 | 2017 | 660 | 0.110 |
Why?
|
| Medicare | 1 | 2017 | 325 | 0.110 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 268 | 0.110 |
Why?
|
| Blood Pressure | 4 | 2011 | 658 | 0.110 |
Why?
|
| New York City | 2 | 2006 | 283 | 0.100 |
Why?
|
| Aged, 80 and over | 4 | 2011 | 2790 | 0.090 |
Why?
|
| Heart Failure, Systolic | 1 | 2011 | 4 | 0.090 |
Why?
|
| Aortography | 1 | 2011 | 10 | 0.090 |
Why?
|
| Exercise Therapy | 1 | 2011 | 83 | 0.090 |
Why?
|
| Health Policy | 2 | 2023 | 184 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2003 | 120 | 0.080 |
Why?
|
| Organizational Policy | 1 | 2010 | 26 | 0.080 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2009 | 12 | 0.080 |
Why?
|
| Health Promotion | 2 | 2024 | 691 | 0.080 |
Why?
|
| Length of Stay | 1 | 2010 | 229 | 0.070 |
Why?
|
| Community Networks | 2 | 2006 | 106 | 0.070 |
Why?
|
| Health Literacy | 1 | 2010 | 120 | 0.070 |
Why?
|
| Echocardiography | 2 | 2011 | 167 | 0.070 |
Why?
|
| Patient Selection | 1 | 2009 | 192 | 0.070 |
Why?
|
| Exercise | 1 | 2013 | 674 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2007 | 19 | 0.060 |
Why?
|
| Radionuclide Imaging | 1 | 2006 | 29 | 0.060 |
Why?
|
| Medical Audit | 1 | 2006 | 26 | 0.060 |
Why?
|
| Adolescent | 1 | 2017 | 5949 | 0.060 |
Why?
|
| Physical Examination | 1 | 2006 | 45 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 249 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2013 | 362 | 0.060 |
Why?
|
| Aorta, Abdominal | 1 | 2024 | 17 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 134 | 0.050 |
Why?
|
| Japan | 1 | 2025 | 347 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2010 | 702 | 0.050 |
Why?
|
| Medical Assistance | 1 | 2023 | 6 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 437 | 0.050 |
Why?
|
| Writing | 1 | 2023 | 41 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2025 | 357 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2005 | 243 | 0.050 |
Why?
|
| Hirudin Therapy | 1 | 2003 | 1 | 0.050 |
Why?
|
| Vena Cava, Inferior | 1 | 2003 | 7 | 0.050 |
Why?
|
| Heart Atria | 1 | 2003 | 28 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 250 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2005 | 208 | 0.050 |
Why?
|
| Heart | 1 | 2024 | 181 | 0.050 |
Why?
|
| Warfarin | 1 | 2003 | 65 | 0.050 |
Why?
|
| Cultural Diversity | 1 | 2023 | 187 | 0.050 |
Why?
|
| Mentors | 1 | 2023 | 143 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 309 | 0.050 |
Why?
|
| Registries | 2 | 2019 | 430 | 0.040 |
Why?
|
| Exercise Test | 1 | 2001 | 75 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2001 | 31 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 285 | 0.040 |
Why?
|
| Transportation | 1 | 2021 | 27 | 0.040 |
Why?
|
| Home Care Services | 1 | 2021 | 37 | 0.040 |
Why?
|
| Social Work | 1 | 2021 | 51 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2001 | 123 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2021 | 177 | 0.040 |
Why?
|
| Autopsy | 1 | 1998 | 46 | 0.040 |
Why?
|
| Health Education | 1 | 2021 | 358 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3073 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 1221 | 0.030 |
Why?
|
| Acute Disease | 1 | 2016 | 156 | 0.030 |
Why?
|
| Chest Pain | 1 | 2011 | 49 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2010 | 90 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 541 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 350 | 0.020 |
Why?
|
| Social Support | 1 | 2010 | 437 | 0.020 |
Why?
|
| South Carolina | 1 | 2006 | 25 | 0.020 |
Why?
|
| North Carolina | 1 | 2006 | 122 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 56 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2005 | 29 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2005 | 162 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2005 | 74 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 224 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 249 | 0.010 |
Why?
|
| Alleles | 1 | 2005 | 351 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2005 | 158 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 454 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 261 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 727 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 858 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 663 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 1051 | 0.010 |
Why?
|